We are live on ! Find out more

1,619 hedge funds and large institutions have $126B invested in Merck in 2014 Q3 according to their latest regulatory filings, with 65 funds opening new positions, 602 increasing their positions, 699 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more first-time investments, than exits

New positions opened: 65 | Existing positions closed: 53

5% more funds holding in top 10

Funds holding in top 10: 140147 (+7)

0% more call options, than puts

Call options by funds: $950M | Put options by funds: $950M

0% less funds holding

Funds holding: 1,6211,619 (-2)

1% less capital invested

Capital invested by funds: $127B → $126B (-$978M)

1.04% less ownership

Funds ownership: 78.25%77.21% (-1%)

14% less repeat investments, than reductions

Existing positions increased: 602 | Existing positions reduced: 699

Holders
1,619
Holders Change
-2
Holders Change %
-0.12%
% of All Funds
46.95%
Holding in Top 10
147
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+5%
% of All Funds
4.26%
New
65
Increased
602
Reduced
699
Closed
53
Calls
$950M
Puts
$950M
Net Calls
+$352K
Net Calls Change
-$100M
Name Holding Trade Value Shares
Change
Change in
Stake
MPWT
951
MassMutual Private Wealth & Trust
Connecticut
$1.87M +$788K +14,032 +74%
BCB
952
Brian C. Broderick
$1.86M -$36.8K -656 -2%
WAM
953
Wolverine Asset Management
Illinois
$1.86M -$1.98M -35,203 -52%
CEP
954
Chicago Equity Partners
Illinois
$1.86M +$98K +1,745 +6%
MCM
955
Maryland Capital Management
Maryland
$1.85M +$8.14K +145 +0.4%
PVWM
956
Point View Wealth Management
New Jersey
$1.84M -$2.36K -42 -0.1%
SFU
957
Stonehage Fleming (UK)
United Kingdom
$1.84M +$388K +6,917 +27%
RMC
958
Regis Management Company
California
$1.84M -$1.56M -27,799 -46%
KFS
959
Kurt F. Somerville
$1.83M -$19.7K -351 -1%
OWD
960
Osborn Williams & Donohoe
Ohio
$1.83M -$47.1K -838 -3%
Capstone Investment Advisors
961
Capstone Investment Advisors
New York
$1.83M -$2.82M -50,147 -61%
MSS
962
Mitchell Sinkler & Starr
Pennsylvania
$1.82M +$16.2K +289 +0.9%
GVT
963
Genesee Valley Trust
New York
$1.81M +$788K +14,025 +78%
FC
964
FIC Capital
New York
$1.81M -$41.2K -734 -2%
HIC
965
Harvey Investment Company
Kentucky
$1.8M
MCC
966
Mid Continent Capital
Illinois
$1.8M -$17.6K -314 -1%
WA
967
WFG Advisors
Texas
$1.79M -$38.2K -681 -2%
PFM
968
PacWest Financial Management
Arizona
$1.78M -$6.79K -121 -0.4%
HCC
969
Hirtle Callaghan & Co
Pennsylvania
$1.78M -$15.8K -282 -0.9%
BAM
970
Brave Asset Management
New Jersey
$1.77M -$749K -13,344 -30%
ST
971
Spinnaker Trust
Maine
$1.76M -$23.5K -419 -1%
GIP
972
Granite Investment Partners
California
$1.74M
HC
973
HHG & Company
Connecticut
$1.74M +$23K +409 +1%
GF
974
Gerry Farber
New York
$1.73M -$824K -14,672 -32%
MC
975
Mathes Company
New York
$1.72M -$41.2K -733 -2%

MRK Hedge Fund Activity: Q3 2014 in Review

1,619 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q3 2014, worth a combined $126B — down 0.77% from $127B a quarter earlier.

Buyers outnumbered sellers: 65 funds opened new MRK positions and 53 closed out — a net gain of 12 holders — while 602 added to existing stakes and 699 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $434M. The largest seller was Norges Bank, cutting an estimated $1.3B.

  • 1,619 institutional investors held Merck (MRK) as of Q3 2014, down from 1,621 in Q2 2014.
  • Funds reported $126B of Merck stock for Q3 2014, down 0.77% quarter-over-quarter.
  • 65 funds opened new Merck positions in Q3 2014 and 53 closed out, a net change of +12 holders.
  • The largest Merck buyer in Q3 2014 was JP Morgan Chase, an estimated $434M added.
  • The largest Merck seller in Q3 2014 was Norges Bank, an estimated $1.3B sold.

Based on aggregated 13F filings for Q3 2014.